Document:

Exhibit 10.7

 

 

 

Service
Agreement

 

Company to be covered:

One World Pharma, Inc.

 

This Service Agreement
(the “Agreement”) is by and between Integrity Media, Inc., a Nevada corporation (“IMI”), and One
World Pharma, Inc. (OWP), a Nevada corporation (the “COMPANY”). This Agreement is made effective as of February
18, 2019 (the “Effective Date”). IMI and the COMPANY are referred to herein individually as a “Party”
and collectively as the “Parties”.

 

		I.	SERVICES TO THE COMPANY BY
IMI.

 

IMI
agrees to provide the following services to the COMPANY (the “Services”) for February 18, 2019 – February
17, 2020:

 

		(1)	IMI hereby agrees to provide Investor Relations services
to the COMPANY including:

 

		(a)	IMI will become the COMPANY’s Investor Relations
agency of record with dedicated phone support and email response for COMPANY shareholders and other interested parties.

		(b)	Press release conception and distribution with actual wire costs to be billed
to the COMPANY directly by the preferred newswire service.

		(c)	IMI will negotiate discounted press release distribution.

		(d)	Financial Media Outreach to microcap friendly or journalists in the COMPANY’S industry or industries.

		(e)	Assistance in crafting Investor Relations copy and collateral as reasonably
needed by the COMPANY with periodic updates (decks, earnings, etc.)

		(f)	IMI will provide guidance and assistance in choosing any supplemental exposure
programs and in assisting the Company’s use of ethical and compliant media partners. IMI will negotiate discounts on paid
media whenever possible.

		(g)	Message board monitoring and general sentiment review, with subsequent reporting
to COMPANY senior management and applied communications.

		(h)	General consulting and assistance in financial communication, positioning
and market strategy.

		(i)	IMI will make introductions to potentially beneficial partners, as possible,
for business development and other benefits.

		(j)	As desired, IMI will host and officiate a weekly Communications Strategy
conference call with Company C-Level execs and consultants.

		(k)	Interview prep and/or public speaking coaching for all events, news ops,
etc.

 

(2)          The
COMPANY will provide and approve any content it requests IMI to distribute on its behalf. IMI will edit, comment and suggest copy
changes for the COMPANY; however, the COMPANY is responsible for creating or supplying all original content and for approval of
the finished copy and content and thus will take full responsibility for that content.

 

    1 

     

    

 

(3)           The Parties understand that the Services are designed to expose the COMPANY to the investing public. IMI makes no
warranties or guarantees that such exposure will create volume, buying, or price appreciation for the COMPANY’S securities.

 

		II.	COMPENSATION TO IMI

 

As compensation for the Services, the COMPANY shall issue to
IMI Restricted Rule 144 shares of the COMPANY’S common stock (the “Payment Shares”). A certificate
for 30,000 shares shall be issued and delivered within 30 calendar days of execution of this agreement. The Payment Shares
issued to IMI shall be deemed to be a fully earned, non-refundable, non-apportionable, and non-ratable retainer. Consequently,
the Payment Shares shall be deemed to be fully paid and non-assessable and thus not a payment for future services. If the COMPANY
decides to terminate this Agreement for any reason whatsoever, it is agreed and understood that IMI will not be requested or demanded
by the COMPANY to return any of the Payment Shares. Shares should be issued in the corporate name “Integrity Media Inc.”

 

Following the applicable
holding period for the Payment Shares, and upon the written request of IMI, the COMPANY agrees to provide, at its own expense,
a valid written legal opinion relative to the sale or proposed sale of the Payment Shares within ten calendar days. The COMPANY
further agrees to cooperate with IMI in having the Rule 144 legend removed from the certificate(s) representing the Payment Shares.
The COMPANY shall not obstruct IMI’s sale of the Payment Shares in any way. The COMPANY agrees to record this agreement
in their next available public filing.

 

As
further compensation for the Services, the COMPANY shall pay IMI $4,000 per month due at the beginning of each 30 day period
from the contract date.

 

		III.	MISCELLANEOUS

 

		A.	Indemnification. Because IMI must at all
times rely upon the accuracy and completeness of information supplied to it by the COMPANY, the COMPANY agrees that IMI will not
be held liable for the accuracy of any information provided by the COMPANY. The COMPANY further agrees to indemnify, hold harmless,
and defend, IMI, including its officers, directors, agents, attorneys, employees and other representatives, at its expense in
any proceeding or suit, which may arise out of or due to (i) the negligence of the COMPANY or its officers, directors, agents,
attorneys, employees or other representatives that may arise from the inaccuracy or incompleteness of such material supplied by
the COMPANY to IMI, or (ii) any breach of any covenant or warranty of the COMPANY in this Agreement.

 

		B.	Authority; Status. Each Party represents that it has the authority
to enter into this Agreement. Each Party acknowledges and agrees that the relationship between the Parties hereto is that of an
independent contractor.

 

		To IMI:	Integrity Media, Inc.

Attn: Kurt Divich, President

12106
Rojo Roma Ave.

Las Vegas, Nevada 89138

Telephone: (702) 396-1000

 

		To COMPANY:	One Wold Pharma Ventures, Inc

Attn: Craig Ellins

3471 W. Oquendo Rd,
Suite 301

Las
Vegas, NV 89118

 

    2 

     

    

 

		D.	Governing Law; Exclusive Jurisdiction and Venue.
This Agreement and the rights of the Parties hereunder shall be interpreted, construed, and governed according to the laws
of the State of California, including all matters of construction, validity, performance, and enforcement and without giving effect
to the principles of conflict of laws. The Parties agree that the Courts of the County of Orange, State of California shall have
sole and exclusive jurisdiction and venue for the resolution of all disputes arising under the terms of this Agreement and the
transactions contemplated herein. The COMPANY also agrees to record this agreement in its next public filing.

 

		E.	Legal Construction. If one or more of the
provisions contained in this Agreement shall for any reason be held to be invalid, illegal, or unenforceable in any respect, the
remaining provisions of this Agreement shall remain in full force and effect as if such invalid, illegal, or unenforceable provision
had never comprised a part of the Agreement.

 

		F.	Attorneys’ Fees. In the event any Party
hereto shall commence legal proceedings against the other to enforce the terms hereof, or to declare rights hereunder, as the
result of a breach of any covenant or condition of this Agreement, the prevailing party in any such proceeding shall be entitled
to recover from the losing party its costs of suit, including reasonable attorneys' fees, as may be fixed by the court.

 

IN
WITNESS WHEREOF, the Parties have caused their duly authorized officers to execute this Agreement, on the dates below indicated.

 

	ONE WORLD PHARMA, INC.	 	INTEGRITY MEDIA, INC.
	 	 	 
	/s/ Craig Ellins	 	/s/ Kurt Divich
	By:	 Craig Ellins	 	By:	 Kurt Divich
	Its:  	CEO	 	Its: 	President

 

 

3Exhibit 10.8

 

OWP VENTURES, INC.

 

CONVERTIBLE PROMISSORY NOTE PURCHASE
AGREEMENT

 

THIS CONVERTIBLE PROMISSORY
NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of January 14, 2019 (the “Effective
Date”), is entered into by and among OWP Ventures, Inc., a Delaware corporation (the “Company”),
and the undersigned investors (individually an “Investor” and collectively, the “Investors”).

 

RECITALS

 

WHEREAS, the
Company has agreed to issue and sell, and Investors have agreed to purchase, Notes (as defined below), subject to the conditions
specified herein.

 

AGREEMENT

 

NOW, THEREFORE,
in consideration of the foregoing, and the representations, warranties, covenants and conditions set forth below, the Company and
Investors, intending to be legally bound, hereby agree as follows:

 

1. Authorization
of Notes. The Company has authorized the issuance and sale, in accordance with the terms hereof, of Convertible Promissory
Notes in the amounts set forth on each Investor’s respective signature page, substantially in the form attached as Exhibit
A hereto (each a “Note” and collectively, the “Notes”).

 

2. Sale
and Issuance of the Notes. At the Initial Closing, the Company shall sell and issue to each Investor, and each Investor
shall purchase and acquire from the Company, upon the terms and conditions set forth herein, a Note in the original principal amount
as is set forth on each Investor’s respective signature page.

 

3.
Closing of Sale of Notes. 

 

(a) Closing.
The closing of the sale and purchase of the Notes (the “Initial Closing”) shall be held on the Effective
Date, or at such other time as the Company and the Investors may mutually agree (such date is hereinafter referred to as the “Closing
Date”). In the event there is more than one closing (each subsequent closing, a “Subsequent Closing”),
the term “Closing” shall apply to both the Initial Closing and the Subsequent Closing unless otherwise
specified.

 

(b) Delivery.
At each Closing (i) each Investor shall deliver to the Company a check or wire transfer funds or conversion of indebtedness
in the amount of such Investor’s Note amount; and (ii) the Company shall issue and deliver to each Investor a Note in favor
of the Investor payable in the principal amount of the Investor’s Note amount.

 

     

     

    

 

4. Representations
and Warranties of the Company. The Company represents and warrants to the Investors as follows as of the initial closing:

 

(a) Organization,
Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware. The Company has the requisite corporate power to own and operate its properties and assets and to
carry on its business as now conducted and as proposed to be conducted. The Company is duly qualified and is authorized to do business
as a foreign entity and is in good standing in each jurisdiction in which it does business, except where the failure to so qualify
would not have a material adverse effect on the business, financial condition, results of operations, assets or liabilities of
the Company.

 

(b) Corporate Power.
The Company will have at the Initial Closing all requisite corporate power to execute and deliver this Agreement and each Note
(collectively the “Note Documents”) and to carry out and perform its obligations under the terms of the
Note Documents.

 

(c) Authorization.
All corporate action on the part of the Company, its directors and its stockholders necessary for the authorization, execution,
delivery and performance of this Agreement by the Company and the performance of the Company’s obligations hereunder, including
the issuance and delivery of the Notes. The Note Documents, when executed and delivered by the Company, shall constitute valid
and binding obligations of the Company enforceable in accordance with their terms, subject to laws of general application relating
to bankruptcy, insolvency, the relief of debtors and, with respect to rights to indemnity, subject to federal and state securities
laws.

 

(d) Offering.
Assuming the accuracy of the representations and warranties of the Investors contained in Section 5 hereof, the offer, issue,
and sale of the Notes are and will be exempt from the registration and prospectus delivery requirements of the Securities Act of
1933, as amended (the “Act”), and have been registered or qualified (or are exempt from registration
and qualification) under the registration, permit, or qualification requirements of all applicable state securities law.

 

5.
Representations and Warranties of the Investor to the Company. Each Investor represents and warrants to the Company
that:

 

(a) Purchase for Own
Account. Each Investor represents that it is acquiring the Notes solely for its own account and beneficial interest for investment
and not for sale or with a view to distribution of the Notes or any securities issuable upon conversion thereof (“Securities”)
or any part thereof, has no present intention of selling (in connection with a distribution or otherwise), granting any participation
in, or otherwise distributing the same, and does not presently have reason to anticipate a change in such intention.

 

(b) Information and
Sophistication. Without lessening or obviating the representations and warranties of the Company set forth in Section 4, each
Investor hereby: (i) acknowledges that it has received all the information it has requested from the Company and it considers necessary
or appropriate for deciding whether to acquire the Notes, (ii) represents that it has had an opportunity to ask questions and receive
answers from the Company regarding the terms and conditions of the offering of the Notes and to obtain any additional information
necessary to verify the accuracy of the information given to the Investor and (iii) further represents that it has such knowledge
and experience in financial and business matters that it is capable of evaluating the merits and risk of this investment.

 

(c) Ability to Bear
Economic Risk. Each Investor acknowledges that investment in the Notes involves a high degree of risk, and represents that
it is able, without materially impairing its financial condition, to hold the Notes for an indefinite period of time and to suffer
a complete loss of its investment.

 

    2

     

    

 

(d) Further Limitations
on Disposition. Without in any way limiting the representations set forth above, each Investor further agrees not to make any
disposition of all or any portion of the Notes unless and until:

 

(i) There
is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance
with such registration statement; or

 

(ii) Investor
shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the
circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Investor shall have furnished
the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration
under the Act or any applicable state securities laws, provided that no such opinion shall be required for dispositions in compliance
with Rule 144.

 

(iii) Notwithstanding
the provisions of paragraphs (i) and (ii) above, no such registration statement or opinion of counsel shall be necessary for a
transfer by such Investor to a partner (or retired partner) or member (or retired member) of the Investor in accordance with partnership
or limited liability company interests, or transfers by gift, will or intestate succession to any spouse or lineal descendants
or ancestors, if all transferees agree in writing to be subject to the terms hereof to the same extent as if they were Investors
hereunder.

 

(e) Accredited Investor
Status. Each Investor is an “accredited investor” as such term is defined in Rule 501 under the Act.

 

(f) Further Assurances.
Each Investor agrees and covenants that at any time and from time to time it will promptly execute and deliver to the Company such
further instruments and documents and take such further action as the Company may be reasonably require in order to carry out the
full intent and purposes of this Agreement and to comply with state or federal securities laws or other regulatory approvals.

 

6. Miscellaneous.

 

(a) Binding Agreement. The terms
and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the
parties. Nothing in this Agreement, expressed or implied, is intended to confer upon any third party any rights, remedies, obligations,
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

 

(b) Governing Law.
This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to
conflicts of laws principles.

 

(c) Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which taken together shall
constitute one and the same instrument.

 

(d) Titles and Subtitles.
The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting
this Agreement.

 

    3

     

    

 

(e) Notices. All
notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to
the party to be notified, (b) when sent by confirmed telex, electronic mail or facsimile if sent during normal business hours of
the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying
next day delivery, with written verification of receipt. All communications shall be sent to the Investors at the addresses set
forth on each Investor’s respective signature page, or at such other addresses as the Investors may designate by ten (10)
days’ advance written notice to the other party hereto. All communications shall be sent to 2110 E. 5th Avenue, Ronkonkoma,
NY 11779, Attn: Craig Ellins, or at such other address as the Company or may designate by ten (10) days’ advance written
notice to the Investor.

 

(f) Modification;
Waiver. No modification or waiver of any provision of this Agreement, other than pursuant to Section 3(b), or consent to departure
therefrom shall be effective unless in writing and approved by the Company and Investors holding at least a majority of the aggregate
principal amount of the Notes then outstanding (the “Required Investors”). Any provision of the Notes
may be amended or waived by the written consent of the Company and Required Investors.

 

(g) Expenses.
The Company and each Investor shall each bear its respective expenses and legal fees incurred with respect to this Agreement and
the transactions contemplated herein.

 

(h) Delays or Omissions.
It is agreed that no delay or omission to exercise any right, power or remedy accruing to the Investors upon any breach or default
of the Company under this Agreement or any Note shall impair any such right, power or remedy, nor shall it be construed to be a
waiver of any such breach or default, or any acquiescence therein, or of or in any similar breach or default thereafter occurring;
nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter
occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character by Investors of any breach
or default under this Agreement, or any waiver by Investors of any provisions or conditions of this Agreement must be in writing
and shall be effective only to the extent specifically set forth in writing and that all remedies, either under this Agreement,
or by law or otherwise afforded to the Investors, shall be cumulative and not alternative. If any action at law or in equity (including
arbitration) is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable
attorneys’ fees, costs and disbursements in addition to any other relief to which such party may be entitled.

 

(i) Entire Agreement.
This Agreement and the Exhibits hereto constitute the full and entire understanding and agreement between the parties with regard
to the subjects hereof and no party shall be liable or bound to any other party in any manner by any representations, warranties,
covenants and agreements except as specifically set forth herein.

 

[Signature Pages Follow]

 

    4

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Note Purchase Agreement as of the date first written above.

 

	 	COMPANY:
	 	 
	 	OWP VENTURES, INC.
	 	 	 
	 	By:	/s/ Craig Ellins
	 	Name:	Craig Ellins
	 	Title:	Chief Executive Officer

 

 

 

Company Signature Page to Note Purchase
Agreement

 

    5

     

    

 

IN WITNESS WHEREOF,
the Investor has executed this Note Purchase Agreement as of January 18, 2019. The Investor hereby authorizes the Company
to append this counterpart signature page to this Agreement as evidence thereof. The undersigned hereby subscribes for the purchase
of a Note (as defined in this Agreement) in the original principal amount specified below.

 

Original Principal Amount of Note Subscribed
For: $500,000.00

 

	Acknowledged and Accepted:	 
	 	 
	INVESTOR:	 
	 	 
	The Sanguine Group LLC.	 
	(Print Full Name of Investor)	 
	 	 
	By:	/s/ Robert du Punton	 
	Name:	Robert du Punton	 
	Title:	Director	 

 

	Address:	6231 PGA Blvd. Suite 104-570	 
	 	 	 
	 	Palm Beach Gardens, FL.33418	 

 

 

 

Investor Signature Page to Note Purchase
Agreement

 

    6

     

    

 

Exhibit A

 

Form of Convertible Promissory Note

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]